Bahram Bodaghi Selected Research

Neurologic Manifestations (Neurological Manifestations)

1/2020	Linezolid-Associated Neurologic Adverse Events in Patients with Multidrug-Resistant Tuberculosis, France.
11/2007	Fluorescein and indocyanine green angiographies in Susac syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bahram Bodaghi Research Topics

Disease

66	Uveitis 10/2022 - 04/2004
25	Inflammation (Inflammations) 10/2022 - 09/2003
14	Macular Edema 01/2022 - 11/2011
7	Posterior Uveitis 11/2022 - 09/2003
7	Retinal Vasculitis 01/2022 - 03/2007
7	Anterior Uveitis 05/2019 - 01/2011
7	Sarcoidosis (Schaumann Disease) 01/2019 - 02/2005
7	Infections 01/2018 - 09/2002
7	Intraocular Lymphoma 01/2016 - 02/2004
6	Lymphoma (Lymphomas) 01/2021 - 02/2005
6	Panuveitis 01/2021 - 09/2006
5	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 01/2022 - 04/2015
5	Behcet Syndrome (Behcet's Syndrome) 02/2017 - 12/2008
4	Retinitis 03/2022 - 06/2003
4	Glaucoma 01/2022 - 11/2011
4	Cataract (Cataracts) 01/2022 - 11/2011
4	Neoplasms (Cancer) 12/2021 - 02/2005
4	Syphilis 01/2020 - 05/2005
4	Cicatrix (Scar) 01/2019 - 06/2003
4	Uveomeningoencephalitic Syndrome (Vogt Koyanagi Harada Syndrome) 06/2011 - 07/2006
3	Edema (Dropsy) 01/2022 - 09/2011
3	Macular Degeneration (Age-Related Maculopathy) 12/2021 - 01/2017
3	Vasculitis (Vasculitides) 11/2021 - 09/2011
3	Takayasu Arteritis (Arteritis, Takayasu's) 10/2021 - 01/2013
3	Necrosis 01/2019 - 05/2004
3	Tuberculosis (Tuberculoses) 04/2018 - 02/2005
3	Granuloma 01/2016 - 06/2012
2	Toxoplasmosis 03/2022 - 05/2005
2	COVID-19 01/2022 - 01/2021
2	Low Vision (Subnormal Vision) 01/2022 - 01/2017
2	Hemorrhage 12/2021 - 01/2013
2	Ganglion Cysts (Ganglion) 06/2021 - 12/2019
2	Intermediate Uveitis (Chronic Cyclitis) 09/2020 - 01/2011
2	Ocular Tuberculosis 09/2020 - 09/2011
2	Optic Nerve Diseases (Optic Neuropathy) 01/2020 - 12/2014
2	Neurologic Manifestations (Neurological Manifestations) 01/2020 - 11/2007
2	Arthritis (Polyarthritis) 01/2019 - 02/2014
2	Aneurysm (Aneurysms) 12/2018 - 09/2011
2	Autoimmune Diseases (Autoimmune Disease) 01/2017 - 03/2016
2	Brain Diseases (Brain Disorder) 01/2017 - 03/2007
2	Atrophy 10/2016 - 02/2014
2	Retinal Detachment (Retinal Detachments) 01/2013 - 06/2011
2	Cryopyrin-Associated Periodic Syndromes 09/2011 - 01/2010
2	Choroidal Neovascularization 03/2011 - 12/2008
2	Susac Syndrome 11/2007 - 03/2007

Drug/Important Bio-Agent (IBA)

25	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 09/2003
21	Retinaldehyde (Retinal)IBA 01/2022 - 05/2004
14	SteroidsIBA 01/2021 - 09/2003
9	Fluorescein (Funduscein)FDA LinkGeneric 10/2021 - 03/2007
8	Antiviral Agents (Antivirals)IBA 10/2018 - 06/2003
7	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 01/2012
7	Pharmaceutical PreparationsIBA 09/2020 - 04/2007
6	InterferonsIBA 11/2020 - 03/2007
6	Immunosuppressive Agents (Immunosuppressants)IBA 01/2020 - 03/2007
6	Interleukin-10 (Interleukin 10)IBA 12/2017 - 02/2004
6	Interferon-alpha (Interferon Alfa)IBA 05/2015 - 11/2002
5	Dexamethasone (Maxidex)FDA LinkGeneric 10/2022 - 01/2017
5	Indocyanine Green (Cardio-Green)FDA LinkGeneric 03/2022 - 04/2007
5	Adalimumab (Humira)FDA Link 01/2022 - 01/2016
5	Infliximab (Remicade)FDA Link 01/2022 - 01/2016
5	Biological ProductsIBA 11/2020 - 02/2004
4	Methotrexate (Mexate)FDA LinkGeneric 01/2021 - 04/2015
3	CytokinesIBA 01/2022 - 07/2007
3	Tuberculin (PPD)IBA 01/2020 - 12/2011
3	Ranibizumab (Lucentis)FDA Link 01/2019 - 01/2017
3	HLA-B27 Antigen (HLA B27 Antigen)IBA 04/2018 - 04/2004
3	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 12/2017 - 05/2005
3	InterleukinsIBA 01/2016 - 01/2013
3	DNA (Deoxyribonucleic Acid)IBA 10/2005 - 09/2002
2	CreatinineIBA 11/2022 - 03/2007
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2022 - 01/2022
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 03/2007
2	tocilizumab (atlizumab)FDA Link 01/2022 - 07/2014
2	Interleukin-12 (IL 12)IBA 01/2022 - 04/2017
2	brolucizumabIBA 01/2022 - 01/2021
2	Interleukin-6 (Interleukin 6)IBA 01/2022 - 01/2013
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2021 - 07/2014
2	C-Reactive ProteinIBA 01/2020 - 06/2017
2	Colchicine FDA LinkGeneric 10/2019 - 07/2014
2	Antinuclear AntibodiesIBA 01/2019 - 02/2014
2	AntibodiesIBA 01/2019 - 12/2018
2	Tumor Necrosis Factor InhibitorsIBA 10/2017 - 01/2017
2	afliberceptIBA 01/2017 - 01/2017
2	Anti-Bacterial Agents (Antibiotics)IBA 07/2012 - 09/2005
2	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 09/2011 - 01/2010
2	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 09/2011 - 01/2010
2	Bevacizumab (Avastin)FDA Link 03/2011 - 12/2008
2	Prednisone (Sone)FDA LinkGeneric 01/2011 - 03/2007

Therapy/Procedure

31	Therapeutics 03/2022 - 11/2002
5	Immunomodulation 01/2022 - 10/2005
5	Lasers (Laser) 01/2022 - 09/2011
5	Biological Therapy 11/2020 - 04/2017
3	Vitrectomy 12/2021 - 07/2007
3	Immunotherapy 12/2021 - 01/2019
3	Aftercare (After-Treatment) 06/2012 - 06/2003
3	Injections 03/2011 - 06/2003
2	Intravitreal Injections 01/2021 - 12/2019
2	Intraocular Lenses (Intraocular Lens) 01/2018 - 11/2011
2	Drug Therapy (Chemotherapy) 02/2015 - 06/2011
2	Duration of Therapy 01/2012 - 06/2011